CAS 2151853-97-1

MPT0G211

CAS : 2151853-97-1

MPT0G211

Degré de pureté : ≥98%

Masse moléculaire : 293.32g/mol

Ref: 54-BUP12679

MPT0G211

CAS : 2151853-97-1

MPT0G211 is a potent inhibitor of kinases that play a crucial role in the regulation of cell cycle and apoptosis. This compound has strong anticancer activity against both Chinese hamster ovary cells and human cancer cells, making it a promising candidate for medicinal use. MPT0G211 works by binding to the ATP-binding site of protein kinases, inhibiting their activity and leading to apoptosis of cancer cells. It is also an analog of other kinase inhibitors that have been shown to be effective against various types of tumors. With its potent inhibitory effects on kinases, MPT0G211 shows great potential as a therapeutic agent for cancer treatment.

Formule : C₁₇H₁₅N₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 293.32 g/mol

Ref: 3D-BLD85397

MPT0G211

CAS : 2151853-97-1

MPT0G211: oral HDAC6 inhibitor with IC50=0.291 nM, 1000x selectivity, neuroprotective, anti-metastatic, crosses blood-brain barrier for Alzheimer's.

Formule : C₁₇H₁₅N₃O₂

Degré de pureté : 99.93% - 99.98%

Couleur et forme : Solid

Masse moléculaire : 293.32

Ref: TM-T60616